Views & Analysis ‘No going back’ for clinical trials after COVID Trial sites have adapted swiftly to the restrictions of COVID-19, and patients have seen many knock-on benefits as a result.
Views & Analysis How patient insights are changing trial solutions Patients have been asking for patient-centric trial solutions for years – the industry just hasn’t been listening.
Views & Analysis True patient-focused research through decentralised and hybr... How can pharma improve the patient-centricity of its trials during COVID-19 and beyond?
Views & Analysis Boosting the impact of patient services New research from Accenture has revealed that adoption of patient support services hasn’t improved since 2015 despite increasing pharma investment.
Views & Analysis COVID-19 – Delivering a pandemic of change to digital medica... As the world of medicine continues to deal with the impact of the COVID-19 pandemic, clinicians are moving to digital solutions.
Views & Analysis Finding agility in unprecedented times Nicole Farmer, general manager, UK & Ireland at Sanofi Genzyme, tells us how the company aimed for agile adaptation during COVID-19, and how these lessons are driving patient centricity
Digital Axtria Ignite 2025: Madhavi Ramakrishna on leadership, cultu... GSK's Madhavi Ramakrishna was the recipient of one of the annual Axtria Ignite Leadership Awards presented at the invite-only summit.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
